Who to call at GSK plc, and when
Fundz watches for the moments GSK plc starts buying, and tells you who to reach.
- An alert the day GSK plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GSK plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GSK plc. With Fundz connected, it knows.
GSK Forms Strategic Partnership with SBP Group to Launch Bepirovirsen for Chronic Hepatitis B in China
Contract Type
partnership
Description
GSK has entered an exclusive collaboration with SBP Group to accelerate the launch of Bepirovirsen, a potential treatment for chronic hepatitis B in China. This partnership enhances access through over 5,000 medical centers, addressing a significant health priority that affects millions.
Quick answer
GSK Forms Strategic Partnership with SBP Group to Launch Bepirovirsen for Chronic Hepatitis B in China (May 12, 2026).
- What agreement did GSK plc announce on May 12, 2026?
- GSK has entered an exclusive collaboration with SBP Group to accelerate the launch of Bepirovirsen, a potential treatment for chronic hepatitis B in China. This partnership enhances access through over 5,000 medical centers, addressing a significant health priority that affects millions.
- What does GSK plc do?
- GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansGSK plc signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.